Total planned funding: $156,026,044
Allocations
Countries/Regions
Ukraine | $156,026,044 |
Organizational Types
Unknown | $46,522,380 |
Private Contractor | $33,539,191 |
NGO | $30,728,905 |
Own Agency | $17,020,620 |
Multi-lateral Agency | $13,275,607 |
University | $8,416,234 |
Other USG Agency | $3,373,107 |
Implementing Agency | $2,900,000 |
Host Country Government Agency | $250,000 |
Program Areas
Governance and Systems | $65,021,280 |
Treatment | $28,667,752 |
Testing | $24,411,645 |
Prevention | $17,064,337 |
Care | $10,472,463 |
Management and Operations | $10,388,567 |
Budget Codes
OHSS: Health Systems Strengthening | $33,865,022 |
HVCT: Testing: HIV Testing and Counseling | $24,411,645 |
HVSI: Strategic Information | $19,871,424 |
HTXS: Treatment: Adult Treatment | $17,236,638 |
HTXD: Treatment: ARV Drugs | $11,431,114 |
HLAB: Laboratory Infrastructure | $11,284,834 |
HVMS: Management and Operations | $10,388,567 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $8,635,730 |
HVTB: Care: TB/HIV | $6,401,235 |
HVOP: Sexual Prevention: Other Sexual Prevention | $5,834,841 |
HKID: Care: Orphans and Vulnerable Children | $2,096,193 |
HBHC: Care: Adult Care and Support | $1,975,035 |
HMBL: Biomedical Prevention: Blood Safety | $1,883,319 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $293,357 |
HMIN: Biomedical Prevention: Injection Safety | $250,000 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $167,090 |
Top Partner Programs
Not Available:
$34,367,521
Countries/Regions
Chemonics International:
$17,819,470
Countries/Regions
USG Aggregated Agencies:
$12,608,383
Countries/Regions
Deloitte Consulting Limited:
$10,671,511
Countries/Regions